A note from Lutho / Founder
A personal question.
A closer look
at rest.
“I started paying closer attention to my sleep. Over three months of personal tracking, I found myself asking what happens before the night begins — and how daytime stress follows us into it.”
That curiosity became DUSK: a collection shaped by reading about circadian rhythms, stress signalling and neural resilience.
“My hypothesis centres on the transition into sleep. Could that window help us understand what follows? It is a question I’m exploring, not a result I can promise.”
Lutho Founder, Peptide South Africa
Every person is different. Personal tracking and blood markers need clinical context; they cannot establish a safe peptide dose or prove a treatment works.